Anavex Life Sciences Corp. (NASDAQ:$AVXL) reached 75.36% versus a 1-year low price of $2.76. On October 20th, the stock was last seen 3.64% higher, reaching at $4.84. At the most recent session, Anavex shares are 209.92% off its target price of $15, while the market capitalization stands at $207.39 M. In the 1 month period, the stock has seen a 16.35% gain.
Top Holders
Together, institutional investors hold around $48 million or 24.6% in AVXL stock. The top three holders are as follows: Park West Asset Management Llc with $15.42 million, BlackRock, Inc. (NYSE:$BLK) with $7.94 million, and Vanguard Group, Inc. (Privately-Traded) at $7.56 million.
At the end of its June reporting period, 34 institutional holders increased their position in Anavex, by roughly 1,027,476 shares, 19 decreased their position by 213,472 positions, and 15 held their position by 8,972,258 shares. Together, the company saw 10 new institutional investments totaling 178,425 shares.
While not many analysts have released their outlook on Anavex, those that have generally recommend a strong buy option. Overall, the company has 1 average brokerage recommendation.
Featured Image: twitter
